Cetera Investment Advisers Johnson & Johnson Transaction History

Cetera Investment Advisers

$41.3 Billion
Q1 2024

A detailed history of Cetera Investment Advisers transactions in Johnson & Johnson stock. As of the latest transaction made, Cetera Investment Advisers holds 707,273 shares of JNJ stock, worth $103 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

707,273

Previous 104,741 575.26%

Holding current value

$103 Million

Previous $16.6 Million 575.3%

% of portfolio

0.27%

Previous 0.18%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 24, 2024	BUY	$155.22 - $162.74 $93.5 Million - $98.1 Million	602,532 Added 575.26%	707,273 $112 Million
Q1 2024 May 14, 2024	SELL	$155.22 - $162.74 $17.6 Million - $18.5 Million	-113,577 Reduced 52.02%	104,741 $16.6 Million
Q4 2023 Feb 13, 2024	SELL	$145.6 - $158.88 $495,768 - $540,986	-3,405 Reduced 1.54%	218,318 $34.2 Million
Q3 2023 Nov 14, 2023	SELL	$155.75 - $174.48 $377,226 - $422,590	-2,422 Reduced 1.08%	221,723 $34.5 Million
Q2 2023 Aug 09, 2023	SELL	$154.35 - $166.11 $136,136 - $146,509	-882 Reduced 0.39%	224,145 $37.1 Million

Q1 2023 May 15, 2023	BUY	$151.05 - $180.26 $843,916 - $1.01 Million	5,587 Added 2.55%	225,027 $34.9 Million
Q4 2022 Feb 14, 2023	BUY	$160.2 - $179.79 $11.5 Million - $12.9 Million	71,737 Added 48.57%	219,440 $38.8 Million
Q3 2022 Nov 10, 2022	SELL	$161.33 - $179.52 $6.16 Million - $6.85 Million	-38,163 Reduced 20.53%	147,703 $24.1 Million
Q2 2022 Aug 11, 2022	BUY	$168.19 - $186.01 $3.4 Million - $3.76 Million	20,224 Added 12.21%	185,866 $33 Million
Q1 2022 May 13, 2022	BUY	$158.14 - $179.59 $635,722 - $721,951	4,020 Added 2.49%	165,642 $29.4 Million
Q4 2021 Feb 14, 2022	BUY	$155.93 - $173.01 $512,541 - $568,683	3,287 Added 2.08%	161,622 $27.6 Million
Q3 2021 Nov 16, 2021	BUY	$161.5 - $179.47 $146,803 - $163,138	909 Added 0.58%	158,335 $25.6 Million
Q2 2021 Aug 13, 2021	BUY	$159.48 - $171.07 $2.13 Million - $2.29 Million	13,366 Added 9.28%	157,426 $25.9 Million
Q1 2021 May 17, 2021	SELL	$153.07 - $170.48 $686,825 - $764,943	-4,487 Reduced 3.02%	144,060 $23.7 Million
Q4 2020 Feb 17, 2021	BUY	$137.11 - $157.38 $14.6 Million - $16.7 Million	106,404 Added 252.48%	148,547 $23.4 Million
Q3 2020 Nov 13, 2020	BUY	$140.38 - $153.83 $407,242 - $446,260	2,901 Added 7.39%	42,143 $6.27 Million
Q2 2020 Aug 13, 2020	BUY	$128.81 - $155.51 $453,668 - $547,706	3,522 Added 9.86%	39,242 $5.52 Million
Q1 2020 May 08, 2020	BUY	$111.14 - $153.99 $230,170 - $318,913	2,071 Added 6.15%	35,720 $4.68 Million
Q4 2019 Feb 10, 2020	BUY	$127.5 - $146.44 $130,687 - $150,101	1,025 Added 3.14%	33,649 $4.91 Million
Q3 2019 Nov 06, 2019	SELL	$126.95 - $142.14 $148,023 - $165,735	-1,166 Reduced 3.45%	32,624 $4.22 Million
Q2 2019 Aug 12, 2019	BUY	$131.15 - $144.24 $207,217 - $227,899	1,580 Added 4.91%	33,790 $4.71 Million
Q1 2019 May 06, 2019	BUY	$125.72 - $139.79 $19,109 - $21,248	152 Added 0.47%	32,210 $4.51 Million
Q4 2018 Feb 15, 2019	SELL	$122.84 - $147.84 $364,711 - $438,936	-2,969 Reduced 8.48%	32,058 $4.14 Million
Q3 2018 Nov 14, 2018	BUY	$121.58 - $142.88 $236,959 - $278,473	1,949 Added 5.89%	35,027 $4.84 Million
Q2 2018 Aug 14, 2018	SELL	$119.4 - $131.76 $406,915 - $449,038	-3,408 Reduced 9.34%	33,078 $4.01 Million
Q1 2018 May 09, 2018	SELL	$125.1 - $148.14 $240,567 - $284,873	-1,923 Reduced 5.01%	36,486 $4.68 Million
Q4 2017 Feb 08, 2018	BUY	$131.22 - $143.62 $178,327 - $195,179	1,359 Added 3.67%	38,409 $5.36 Million
Q3 2017 Nov 16, 2017	BUY	$129.47 - $135.38 $549,341 - $574,417	4,243 Added 12.93%	37,050 $4.83 Million
Q2 2017 Aug 17, 2017	SELL	N/A	-32,074 Reduced 49.44%	32,807 $4.33 Million
Q2 2017 Aug 14, 2017	BUY	N/A	64,881	64,881 $8.58 Million

Others Institutions Holding JNJ

# of Institutions

4,147

Shares Held

1.64B

Call Options Held

15.1M

Put Options Held

12.1M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.

Account

Cetera Investment Advisers Johnson & Johnson Transaction History